Title:
BICYCLIC PYRIDINONE COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/194287
Kind Code:
A1
Abstract:
Disclosed are a bicyclic pyridinone compound and the use thereof, and particularly disclosed are a compound as shown in formula (I) and a pharmaceutically acceptable salt thereof.
Inventors:
ZHANG SHENGBIN (CN)
YU TAO (CN)
WU CHENGDE (CN)
LIU JINXIN (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
YU TAO (CN)
WU CHENGDE (CN)
LIU JINXIN (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2022/081768
Publication Date:
September 22, 2022
Filing Date:
March 18, 2022
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D403/12; A61K31/501; A61P5/14; C07D237/14
Domestic Patent References:
WO2021050945A1 | 2021-03-18 | |||
WO2020041741A1 | 2020-02-27 |
Other References:
KIRSCHBERG, T. A. ET AL.: "Selective thyroid hormone receptor β agonists with oxadiazolone acid isosteres", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS., vol. 30, 5 August 2020 (2020-08-05), XP086300499, DOI: 10.1016/j.bmcl.2020.127465
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: TEST COMBINATION PACKET AND TEST METHOD
Next Patent: COMMUNICATION METHOD AND APPARATUS
Next Patent: COMMUNICATION METHOD AND APPARATUS